Citation Impact
Citing Papers
Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors
2005
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Osteoarthritis year in review 2019: epidemiology and therapy
2020 Standout
Transcriptional regulation of macrophage polarization: enabling diversity with identity
2011 Standout
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
2012 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity
2010 StandoutNobel
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Detection of rupture-prone atherosclerotic plaques by time-resolved laser-induced fluorescence spectroscopy
2008
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
Type I interferons in infectious disease
2015 Standout
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
2015
Regulation of immunity and oncogenesis by the IRF transcription factor family
2010
Hepatocellular carcinoma
2021 Standout
Human acute myeloid leukemia stem cells
2003
Cancer genes and the pathways they control
2004 Standout
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Structural Imaging in Parkinson’s Disease: New Developments
2019
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
2008 Standout
The efficacy and safety of low-dose radiotherapy on pain and functioning in patients with osteoarthritis: a systematic review
2015
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors
2015 StandoutNobel
Interferon Regulatory Factor 8 Regulates RANTES Gene Transcription in Cooperation with Interferon Regulatory Factor-1, NF-κB, and PU.1
2006
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging
2001
Regulation of type I interferon responses
2013 Standout
Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity
2004
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Identification of human brain tumour initiating cells
2004 StandoutNature
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Comparison of Cytogenetic and Molecular Genetic Detection of t(8;21) and inv(16) in a Prospective Series of Adults With De Novo Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
2001
Intraperitoneal Therapy for Peritoneal Cancer
2010
Tumour stem cells and drug resistance
2005 Standout
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
2006
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 Standout
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
2006 StandoutNature
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein
2005
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Inorganic nanoparticles in porous coordination polymers
2016 StandoutNobel
The IRF Family Transcription Factors in Immunity and Oncogenesis
2008
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
2005 Standout
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
2002
Trial Watch
2012
Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia
2002
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
2009
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis
2020
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
The Biology of Cancer Stem Cells
2007
Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup
2004
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Works of Manuel Schmidt being referenced
Ultra high-field SWI of the substantia nigra at 7T: reliability and consistency of the swallow-tail sign
2017
Catumaxomab: A bispecific trifunctional antibody
2009
Benign painful shoulder syndrome
2012
Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias
1999
Intestinal and peritoneal bleeding: detection with an intravascular contrast agent and fast three-dimensional MR imaging--preliminary experience from an experimental study.
1998
Underestimation of inversion (16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation
1997
Intravascular MR imaging of atherosclerotic plaque: ex vivo analysis of human femoral arteries with histologic correlation.
1997
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis
2015
Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α
2001
Preliminary results of a phase II/III clinical study of the TLR9 agonist MGN1703 in patients with advanced colorectal carcinoma with disease control after first-line therapy: IMPACT study.
2011